Coveo is the AI platform for search and product discovery, scalable for enterprise retail and equipped to handle complex B2B catalogs and requirements. We deliver predictive and personalized search, and recommendation experiences that drive revenue. With cutting-edge generative AI and conversational capabilities, Coveo transforms how retailers and B2B businesses help customers discover products, find information, and make confident purchase decisions online. Our platform uniquely blends multiple AI models to balance relevance, personalization, and profitability at scale. With Coveo’s Generative Product Discovery, customers get a conversational, context-aware experience that mimics the guidance of a knowledgeable in-store associate—helping buyers navigate complex product catalogs, find compatible parts, or reorder with confidence. While the Coveo Merchandising Hub gives business teams direct control to shape and optimize results without relying on developers. Whether you serve consumers or professional buyers, Coveo bridges the online experience gap with AI that understands intent and maximizes relevance, personalization, and profitability. Recognized as a Leader in the 2025 Gartner® Magic Quadrant™ for Search and Product Discovery. | Coveo AI-Search helps healthcare systems deliver faster, more personalized care. Patients can quickly find providers, navigate complex sites, and get clear answers. Our AI-search and generative experiences reduce friction, improve access, and support better outcomes, from the moment a patient begins their search to the final follow-up.
Cortechs.ai
Cortechs.ai develops and markets cutting-edge imaging solutions that are used by radiologists, neurologists, and oncologists in hundreds of clinics and research centers around the world. The Cortechs.ai team includes scientists, engineers, business professionals, and clinical specialists working towards the common goal of improving the diagnosis and treatment of patients with neurodegenerative disorders and cancers. Cortechs.ai’s flagship product, NeuroQuant®, is a breakthrough, 510(k) cleared medical device that makes quantitative analysis of MRI images of the human brain a routine part of clinical practice. As the first FDA cleared and CE marked medical device capable of automatically detecting and quantifying atrophy in the human brain, NeuroQuant® brings sophisticated, accurate, and fully automated MRI post-processing capabilities. This provides neurologists, radiologists, and clinical researchers with a convenient and cost-effective means to quantify atrophy of brain structures to help diagnose a variety of brain disorders, including conditions such as Alzheimer’s disease, multiple sclerosis, epilepsy and traumatic brain injury.
Coretek Services
Coretek is a technology consulting firm specializing in secure AI, cloud, and modern workplace solutions. As a Microsoft Solutions Partner, Coretek helps organizations design, deploy, and govern AI and security strategies that enable innovation without compromising trust. Headquartered in Farmington Hills, Michigan, Coretek supports enterprises across healthcare, manufacturing, financial services, and the public sector.
Coreline Soft
Coreline Soft is a leading medical AI company specializing in automated thoracic imaging analysis. Its flagship platform, AVIEW, provides a comprehensive suite of AI-powered tools for lung cancer screening, COPD, coronary calcium scoring, and other chest CT applications. The company’s AI solutions are clinically validated and deployed in national screening programs across multiple countries, supporting radiologists with standardized, efficient, and scalable workflows. Coreline’s mission is to empower healthcare providers to detect, quantify, and manage thoracic diseases earlier and more effectively through cutting-edge AI technology and seamless PACS integration.
Coral AI
Coral AI is an end-to-end intake automation platform that uses AI technology paired with best-in-class operations and logistics reasoning to reduce intake workload by at
ControlUp, Inc.
ControlUp unifies IT operations and digital employee experience (DEX) in a single platform, giving healthcare IT teams real-time visibility, intelligent automation, proactive remediation, and actionable experience insights. By bringing every endpoint, application, and user into one view, ControlUp helps resolve issues before they disrupt staff, ensuring uninterrupted access to critical systems and patient data. The result is a friction-free digital workplace and better DEX, so care teams can stay focused on what matters most: improving patient outcomes. | ControlUp unifies IT operations and digital employee experience (DEX) in a single platform, giving healthcare IT teams real-time visibility, intelligent automation, proactive remediation, and actionable experience insights. By bringing every endpoint, application, and user into one view, ControlUp helps resolve issues before they disrupt staff, ensuring uninterrupted access to critical systems and patient data so care teams can stay focused on what matters most: improving patient outcomes.
ContextVision
ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X -ray and MRI equipment around the world. Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. Building on more than 40 years of leadership in medical image enhancement, ContextVision is advancing its legacy through the transformation to Data Quality— a focused ultrasound program that leverages AI-powered image-enhancements to enable organ and disease specific quantitative imaging solutions to point-of-care ultrasound. The goal is to deliver a more rapid and accurate detection as well as staging of chronic conditions, such as MASLD (Metabolic dysfunction-associated steatotic liver disease). By combining organ-specific image enhancement, user-independent workflows, as well as quantitative disease-specific digital biomarkers, the platform is being built to support near-patient diagnostic solutions.